CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.124
-0.003 (-2.52%)
At close: Nov 20, 2024, 4:00 PM
0.130
+0.006 (4.77%)
Pre-market: Nov 21, 2024, 5:44 AM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $6.13 million as of November 21, 2024. Its market cap has decreased by -13.20% in one year.
Market Cap
6.13M
Enterprise Value
-814.48K
1-Year Change
-13.20%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $71.80M to $6.13M, a decrease of -91.47%. That is a compound annual growth rate of -38.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 6.13M | -8.07% |
| Dec 29, 2023 | 6.67M | 108.14% |
| Dec 30, 2022 | 3.20M | -83.67% |
| Dec 31, 2021 | 19.61M | -52.32% |
| Dec 31, 2020 | 41.13M | -36.70% |
| Dec 31, 2019 | 64.97M | -9.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 6.12M |
| Xenetic Biosciences | 6.08M |
| Alzamend Neuro | 6.04M |
| Intelligent Bio Solutions | 5.99M |
| Ainos | 5.96M |
| Viracta Therapeutics | 5.91M |
| NewGenIvf Group | 5.89M |
| Organovo Holdings | 5.84M |